T(16;16)

Clinical trials for T(16;16) explained in plain language.

Never miss a new study

Get alerted when new T(16;16) trials appear

Sign up with your email to follow new studies for T(16;16), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo targets hard-to-treat leukemia in early trial

Disease control Recruiting now

This study tests a mix of chemotherapy drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome. The goal is to see how well the treatment kills cancer cells and what side effects it causes. About 270 adults will …

Matched conditions: T(16;16)

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 05, 2026 11:52 UTC

T(16;16)

Get alerted when new T(16;16) trials appear

New drug combo targets hard-to-treat leukemia in early trial